Generation Bio Co Stock Performance

GBIO Stock  USD 4.62  0.42  10.00%   
On a scale of 0 to 100, Generation Bio holds a performance score of 2. The company retains a Market Volatility (i.e., Beta) of 2.07, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Generation Bio will likely underperform. Please check Generation Bio's sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to make a quick decision on whether Generation Bio's current trending patterns will revert.

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Generation Bio Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady forward indicators, Generation Bio displayed solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
11.87
Five Day Return
5.82
Year To Date Return
(57.67)
Ten Year Return
(98.10)
All Time Return
(98.10)
Last Split Factor
1:10
Last Split Date
2025-07-22
1
Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results
05/07/2025
2
Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference GBIO Stock News
05/28/2025
3
Acquisition by Appelhans Dannielle of 30000 shares of Generation Bio at 0.3874 subject to Rule 16b-3
06/04/2025
4
Generation Bio Elects Directors and Approves Key Proposals - TipRanks
06/05/2025
5
Acquisition by Stehman-breen Catherine of 30000 shares of Generation Bio at 0.3874 subject to Rule 16b-3
06/06/2025
6
Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635
07/07/2025
7
Disposition of 5273 shares by Mcdonough Geoff of Generation Bio subject to Rule 16b-3
07/15/2025
8
Acquisition by Nicholson Donald William of 30000 shares of Generation Bio at 0.3874 subject to Rule 16b-3
07/16/2025
9
Generation Bio Announces 1-for-10 Reverse Stock Split GBIO Stock News
07/18/2025
10
BlackRock, Inc. Reduces Stake in Generation Bio Co by 66.17
07/24/2025
Begin Period Cash Flow72.2 M
Total Cashflows From Investing Activities94.5 M

Generation Bio Relative Risk vs. Return Landscape

If you would invest  431.00  in Generation Bio Co on April 26, 2025 and sell it today you would lose (11.00) from holding Generation Bio Co or give up 2.55% of portfolio value over 90 days. Generation Bio Co is currently generating 0.229% in daily expected returns and assumes 7.5503% risk (volatility on return distribution) over the 90 days horizon. In different words, 67% of stocks are less volatile than Generation, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Generation Bio is expected to generate 9.67 times more return on investment than the market. However, the company is 9.67 times more volatile than its market benchmark. It trades about 0.03 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.22 per unit of risk.

Generation Bio Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Generation Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Generation Bio Co, and traders can use it to determine the average amount a Generation Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0303

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsGBIO
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 7.55
  actual daily
67
67% of assets are less volatile

Expected Return

 0.23
  actual daily
4
96% of assets have higher returns

Risk-Adjusted Return

 0.03
  actual daily
2
98% of assets perform better
Based on monthly moving average Generation Bio is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Generation Bio by adding it to a well-diversified portfolio.

Generation Bio Fundamentals Growth

Generation Stock prices reflect investors' perceptions of the future prospects and financial health of Generation Bio, and Generation Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Generation Stock performance.

About Generation Bio Performance

By examining Generation Bio's fundamental ratios, stakeholders can obtain critical insights into Generation Bio's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Generation Bio is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.57)(0.60)
Return On Capital Employed(0.73)(0.76)
Return On Assets(0.57)(0.60)
Return On Equity(1.53)(1.45)

Things to note about Generation Bio performance evaluation

Checking the ongoing alerts about Generation Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Generation Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Generation Bio had very high historical volatility over the last 90 days
Generation Bio has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 19.89 M. Net Loss for the year was (131.67 M) with loss before overhead, payroll, taxes, and interest of (24.16 M).
Generation Bio Co currently holds about 301.17 M in cash with (88.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.07, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Generation Bio has a poor financial position based on the latest SEC disclosures
Roughly 72.0% of the company shares are owned by institutional investors
Latest headline from gurufocus.com: BlackRock, Inc. Reduces Stake in Generation Bio Co by 66.17
Evaluating Generation Bio's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Generation Bio's stock performance include:
  • Analyzing Generation Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Generation Bio's stock is overvalued or undervalued compared to its peers.
  • Examining Generation Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Generation Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Generation Bio's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Generation Bio's stock. These opinions can provide insight into Generation Bio's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Generation Bio's stock performance is not an exact science, and many factors can impact Generation Bio's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Generation Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Generation Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Generation Bio Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Generation Bio Co Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(10.80)
Revenue Per Share
3.678
Quarterly Revenue Growth
1.149
Return On Assets
(0.19)
Return On Equity
(0.70)
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.